{"id":56063,"date":"2023-04-20T19:03:12","date_gmt":"2023-04-20T17:03:12","guid":{"rendered":"https:\/\/pharma-trend.com\/en\/38-879-billion-heart-failure-devices-markets-global-forecast-to-2029-researchandmarkets-com\/"},"modified":"2023-04-20T19:03:12","modified_gmt":"2023-04-20T17:03:12","slug":"38-879-billion-heart-failure-devices-markets-global-forecast-to-2029-researchandmarkets-com","status":"publish","type":"post","link":"https:\/\/pharma-trend.com\/en\/38-879-billion-heart-failure-devices-markets-global-forecast-to-2029-researchandmarkets-com\/","title":{"rendered":"$38.879 Billion Heart Failure Devices Markets &#8211; Global Forecast to 2029 &#8211; ResearchAndMarkets.com"},"content":{"rendered":"<div>\n<p>DUBLIN&#8211;(BUSINESS WIRE)&#8211;The <a target=\"_blank\" href=\"https:\/\/www.researchandmarkets.com\/reports\/5745115\/heart-failure-devices-global-market-forecast?utm_source=BW&amp;utm_medium=PressRelease&amp;utm_code=tgxwg7&amp;utm_campaign=1842456+-+%2438.879+Billion+Heart+Failure+Devices+Markets+-+Global+Forecast+to+2029&amp;utm_exec=chdo54prd\" rel=\"nofollow noopener\" shape=\"rect\">&#8220;Heart Failure Devices Global Market &#8211; Forecast To 2029&#8221;<\/a> report has been added to <strong>ResearchAndMarkets.com&#8217;s<\/strong> offering.<\/p>\n<p><a href=\"https:\/\/mms.businesswire.com\/media\/20230420005806\/en\/1770062\/4\/logo.jpg\"><img decoding=\"async\" src=\"https:\/\/mms.businesswire.com\/media\/20230420005806\/en\/1770062\/21\/logo.jpg\"><\/a><\/p>\n<p>\nThe heart failure devices global market expected to grow at high single-digit CAGR from 2022 to 2029 to reach $38,879.9 million by 2029.<\/p>\n<p>\nFactors such as increasing incidence of heart failure diseases, technological advancement in heart failure devices, rising geriatric population, and favorable reimbursement are the drivers, vast pipeline products, increase in funding and approvals are the opportunities.<\/p>\n<p>\nAdverse events and complications with the implantation of heart failure devices, the high cost of the devices, and the lack of trained professionals are the restraints, whereas, stringent regulatory guidelines and the availability of alternative products are the threats.<\/p>\n<p>\nThe heart failure devices global market is segmented based on products, end-users, surgery and geography. The heart failure devices market based on products is segmented as cardiac rhythm products, cardiac assist devices (CAD), structural heart devices (SHD), ECMO and others (modulation devices). Among them, the structural heart device segment commands the largest revenue in 2022 and it is expected to grow at double digit CAGR from 2022 to 2029.<\/p>\n<p>\nNorth America holds the largest revenue in 2022 and it is expected to grow at high single digit CAGR from 2022 to 2029 mainly due to the increasing prevalence of structural heart diseases in the region, persistently elevating geriatric population burdened with various kinds of valvular diseases, increasing preference and adoption of the patient population there for technologically advanced and minimally invasive therapeutic products, availability of advanced imaging and better patient screening programs and increasing investments on research activities for developing innovative and technologically advanced products.<\/p>\n<p>\nThe Asia-Pacific is the fastest-growing region and is expected to grow in double digit CAGR from 2022 to 2029 due to the high structural heart disease burden in the region, increasing geriatric population, increasing demand for better healthcare facilities, increasing penetration of reimbursement schemes in developing countries, increasing demand for highly efficient and minimally invasive products from the value-centric patient population, growing economies of the region, availability of various kinds of heart failure treatment products, increasing patient awareness of these products and increasing medical tourism prospects of the region.<\/p>\n<p>\nThe heart failure devices global market is a consolidated market with the top 8 players. Some of the major players in the heart failure devices market include Medtronic PLC (Ireland), Abbott Laboratories (U.S.), Edwards Lifesciences Corporation (U.S.), Boston Scientific Corporation (U.S.), Abiomed (U.S.), Biotronik (Germany), Getinge (Sweden) and MicroPort (China).<\/p>\n<p>\n<strong>Factors Influencing Market<\/strong><\/p>\n<p>\nDrivers and Opportunities<\/p>\n<ul>\n<li>\nIncreasing Incidence of Heart Failure<\/li>\n<li>\nTechnological Advancements in Heart Failure Devices<\/li>\n<li>\nRising Geriatric Population<\/li>\n<li>\nVast Pipeline Products<\/li>\n<li>\nIncrease in Product Approvals<\/li>\n<li>\nIncrease in Funding<\/li>\n<\/ul>\n<p>\nRestraints and Threats<\/p>\n<ul>\n<li>\nAdverse Events and Complications with the Implantation of Heart Failure Devices<\/li>\n<li>\nHigh Cost of the Devices<\/li>\n<li>\nLack of Skilled and Trained Professionals<\/li>\n<li>\nStringent Regulatory Guidelines<\/li>\n<li>\nAvailability of Alternative Products<\/li>\n<li>\nIncreasing Product Recalls<\/li>\n<\/ul>\n<p>\nRegulatory Affairs<\/p>\n<ul>\n<li>\nCommercialization Regulatory Affairs<\/li>\n<li>\nInternational Organization for Standardization<\/li>\n<li>\nIso 9001: 2015 Quality Management System<\/li>\n<li>\nIso 14644-1 Cleanroom Standards<\/li>\n<li>\nIso 13485 Medical Devices<\/li>\n<li>\nIso 10993 Biological Evaluation of Medical Devices<\/li>\n<li>\nIso 14971: Risk Management of Medical Devices<\/li>\n<li>\nIso 5840: Heart Valve Validation<\/li>\n<li>\nIso 14708-5: Active Implantable Medical Devices &#8211; Part 5: Circulatory Support Devices<\/li>\n<li>\nIec 60601-1 Medical Electrical Equipment Standard<\/li>\n<li>\nIec 60601-1-11 Home Care Safety<\/li>\n<li>\nAstm International Standards<\/li>\n<\/ul>\n<p>\nClinical Trials Data<\/p>\n<p>\nReimbursement Scenario<\/p>\n<ul>\n<li>\nReimbursement Table<\/li>\n<li>\nStructural Heart Device Reimbursement<\/li>\n<li>\nRhythm Management Device Implant Procedures<\/li>\n<li>\nSurgical Valve Repair and Replacement Procedures<\/li>\n<li>\nVentricular Assist Device Reimbursement<\/li>\n<li>\nCad Physician Reimbursement<\/li>\n<\/ul>\n<p>\nTechnological Advancements<\/p>\n<ul>\n<li>\nBionic Pacemaker<\/li>\n<li>\nPulse Vad<\/li>\n<li>\nVadovations Cardiac Assist System<\/li>\n<li>\nTotal Artificial Heart (Tah)<\/li>\n<li>\nFully Implanted Bioresorbable Cardiac Pacemakers Without Leads and Batteries<\/li>\n<li>\nInteratrial Shunt<\/li>\n<li>\nVagus Nerve Stimulation<\/li>\n<li>\nElectrical Microcurrent Therapy<\/li>\n<li>\nContraband<\/li>\n<\/ul>\n<p>\n<strong>Major Companies<\/strong><\/p>\n<ul>\n<li>\nAbbott Laboratories<\/li>\n<li>\nAbiomed<\/li>\n<li>\nBiotronik Se &amp; Co. Kg<\/li>\n<li>\nBoston Scientific Corporation<\/li>\n<li>\nCorcym<\/li>\n<li>\nEdwards Lifesciences Corporation<\/li>\n<li>\nGetinge<\/li>\n<li>\nMedtronic, plc<\/li>\n<li>\nMicroport Scientific Corporation<\/li>\n<li>\nTeleflex Incorporated<\/li>\n<\/ul>\n<p>\n<strong>Companies Mentioned<\/strong><\/p>\n<ul>\n<li>\nAbbott Laboratories (U.S.)<\/li>\n<li>\nAbiomed, Inc. (U.S.)<\/li>\n<li>\nAffluent Medical SA (France)<\/li>\n<li>\nAtriCure, Inc. (U.S.)<\/li>\n<li>\nArtivion (Cryolife) (U.S.)<\/li>\n<li>\nBalton Sp. z o.o (Poland)<\/li>\n<li>\nBerlin Heart GmbH (Germany)<\/li>\n<li>\nBiosensor International (NVT AG) (Singapore)<\/li>\n<li>\nBioStable Science &amp; Engineering, Inc. (U.S.)<\/li>\n<li>\nBiotronik (Germany)<\/li>\n<li>\nBiVacor, Inc (U.S.)<\/li>\n<li>\nBioventrix Inc. (U.S.)<\/li>\n<li>\nBoston Scientific Corporation (U.S.)<\/li>\n<li>\nBraile Biomedica (Brazil)<\/li>\n<li>\nCardia Inc. (U.S.)<\/li>\n<li>\nCardiac Dimensions, Inc. (U.S.)<\/li>\n<li>\nCardioBridge GmbH (Germany)<\/li>\n<li>\nCardioDyme (Reliant Heart) (U.S.)<\/li>\n<li>\nCardiosolutions, Inc. (U.S.)<\/li>\n<li>\nCarmat SA (France)<\/li>\n<li>\nColibri Heart Valve LLC (U.S.)<\/li>\n<li>\nCorcym (U.K.)<\/li>\n<li>\nCoroneo (Mexico)<\/li>\n<li>\nCorvia Medical (U.S.)<\/li>\n<li>\nCorWave S.A. (France)<\/li>\n<li>\nCVRx (U.S.)<\/li>\n<li>\nEdwards Lifesciences Corporation (U.S.)<\/li>\n<li>\nEvaheart, Inc. (U.S.)<\/li>\n<li>\nFOC Medical S.A. (Argentina)<\/li>\n<li>\nFresenius Medical Care AG &amp; Co. KGaA (Xenios AG) (Germany)<\/li>\n<li>\nGenesee BioMedical, Inc. (U.S.)<\/li>\n<li>\nGenesis Medtech (JC Medical) (Singapore)<\/li>\n<li>\nGetinge AB (Maquet Holding) (Sweden)<\/li>\n<li>\nHanyu medical (China)<\/li>\n<li>\nHighLife SAS (France)<\/li>\n<li>\nImpulse Dynamics (Germany)<\/li>\n<li>\nJarvik Heart, Inc. (U.S.)<\/li>\n<li>\nJena Valve Technology, Inc, (U.S.)<\/li>\n<li>\nLabcor Laboratorios Ltda (Brazil)<\/li>\n<li>\nLepu Medical (China)<\/li>\n<li>\nLifetech Scientific (Shenzhen) Co., Ltd. (China)<\/li>\n<li>\nLivaNova PLC (U.K.)<\/li>\n<li>\nMedico SPA (Italy)<\/li>\n<li>\nMedtronic, PLC (Ireland)<\/li>\n<li>\nMeril Life Sciences Pvt. Ltd. (India)<\/li>\n<li>\nMicro Interventional Devices, Inc. (U.S.)<\/li>\n<li>\nMicroPort Scientific Corporation (China)<\/li>\n<li>\nMiTiHeart Corporation (U.S.)<\/li>\n<li>\nMitrAssist Ltd (Israel)<\/li>\n<li>\nNeoChord, Inc. (U.S.)<\/li>\n<li>\nNeoVasc Inc. (Canada)<\/li>\n<li>\nOcclutech International AB (Sweden)<\/li>\n<li>\nP+F Products + Features GmbH (Germany)<\/li>\n<li>\nPeijia Medical Limited (China)<\/li>\n<li>\npfm Medical Ag (Germany)<\/li>\n<li>\nPulse Cath BV (The Netherlands)<\/li>\n<li>\nSahajanand Medical Technologies Ltd. (India)<\/li>\n<li>\nSenko Medical Instrument Mfg. CO., LTD (Japan)<\/li>\n<li>\nSynCardia Systems, LLC (U.S.)<\/li>\n<li>\nStrait Access Technologies (South Africa)<\/li>\n<li>\nTeleflex Incorporated (U.S.)<\/li>\n<li>\nThubrikar Aortic Valve, Inc. (U.S.)<\/li>\n<li>\nTTK Healthcare Limited (TTK Chitra Group) (India)<\/li>\n<li>\nVenus Medtech (China)<\/li>\n<li>\nV-Wave Ltd (Israel)<\/li>\n<li>\nVesalius Cardiovascular Inc. (Canada)<\/li>\n<li>\nW. L. Gore &amp; Associates, Inc. (U.S.)<\/li>\n<li>\nWindmill Cardiovascular systems, Inc. (U.S.)<\/li>\n<li>\nXeltis (The Netherlands)<\/li>\n<li>\nXuzhou Yatai Scientific Co., Ltd (China)<\/li>\n<li>\nZeon Corporation (Japan)<\/li>\n<\/ul>\n<p>\nFor more information about this report visit <a target=\"_blank\" href=\"https:\/\/www.researchandmarkets.com\/reports\/5745115\/heart-failure-devices-global-market-forecast?utm_source=BW&amp;utm_medium=PressRelease&amp;utm_code=tgxwg7&amp;utm_campaign=1842456+-+%2438.879+Billion+Heart+Failure+Devices+Markets+-+Global+Forecast+to+2029&amp;utm_exec=chdo54prd\" rel=\"nofollow noopener\" shape=\"rect\">https:\/\/www.researchandmarkets.com\/r\/1du6ka<\/a><\/p>\n<p>\n<strong>About ResearchAndMarkets.com<\/strong><\/p>\n<p>\nResearchAndMarkets.com is the world&#8217;s leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.<\/p>\n<p> <b>Contacts<\/b> <\/p>\n<p>\nResearchAndMarkets.com<br \/>\n<br \/>Laura Wood, Senior Press Manager<br \/>\n<br \/><a target=\"_blank\" href=\"m&#97;&#x69;&#x6c;&#x74;o&#58;&#x70;&#x72;&#x65;s&#115;&#x40;&#x72;&#x65;s&#101;&#x61;&#x72;&#x63;h&#97;&#x6e;&#x64;&#x6d;a&#114;&#x6b;&#x65;&#x74;s&#46;&#x63;&#x6f;&#x6d;\" rel=\"nofollow noopener\" shape=\"rect\">p&#114;&#x65;&#x73;s&#64;&#x72;&#x65;s&#101;&#x61;&#x72;c&#104;&#x61;&#x6e;d&#109;&#x61;&#x72;k&#101;&#116;&#x73;&#x2e;c&#111;&#x6d;<\/a><br \/>For E.S.T Office Hours Call 1-917-300-0470<br \/>\n<br \/>For U.S.\/ CAN Toll Free Call 1-800-526-8630<br \/>\n<br \/>For GMT Office Hours Call +353-1-416-8900<\/p>\n<\/div>\n","protected":false},"excerpt":{"rendered":"<p>DUBLIN&#8211;(BUSINESS WIRE)&#8211;The &#8220;Heart Failure Devices Global Market &#8211; Forecast To 2029&#8221; report has been added to ResearchAndMarkets.com&#8217;s offering. The heart failure devices global market expected to grow at high single-digit CAGR from 2022 to 2029 to reach $38,879.9 million by 2029. Factors such as increasing incidence of heart failure diseases, technological advancement in heart failure &#8230; <span class=\"more\"><a class=\"more-link\" href=\"https:\/\/pharma-trend.com\/en\/38-879-billion-heart-failure-devices-markets-global-forecast-to-2029-researchandmarkets-com\/\">[Read more&#8230;]<\/a><\/span><\/p>\n","protected":false},"author":4,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[13],"tags":[],"class_list":{"0":"entry","1":"post","2":"publish","3":"author-business","4":"post-56063","6":"format-standard","7":"category-industry"},"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.4 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>$38.879 Billion Heart Failure Devices Markets - Global Forecast to 2029 - ResearchAndMarkets.com - Pharma Trend<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/pharma-trend.com\/en\/38-879-billion-heart-failure-devices-markets-global-forecast-to-2029-researchandmarkets-com\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"$38.879 Billion Heart Failure Devices Markets - Global Forecast to 2029 - ResearchAndMarkets.com - Pharma Trend\" \/>\n<meta property=\"og:description\" content=\"DUBLIN&#8211;(BUSINESS WIRE)&#8211;The &#8220;Heart Failure Devices Global Market &#8211; Forecast To 2029&#8221; report has been added to ResearchAndMarkets.com&#8217;s offering. The heart failure devices global market expected to grow at high single-digit CAGR from 2022 to 2029 to reach $38,879.9 million by 2029. Factors such as increasing incidence of heart failure diseases, technological advancement in heart failure ... [Read more...]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/pharma-trend.com\/en\/38-879-billion-heart-failure-devices-markets-global-forecast-to-2029-researchandmarkets-com\/\" \/>\n<meta property=\"og:site_name\" content=\"Pharma Trend\" \/>\n<meta property=\"article:published_time\" content=\"2023-04-20T17:03:12+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/mms.businesswire.com\/media\/20230420005806\/en\/1770062\/21\/logo.jpg\" \/>\n<meta name=\"author\" content=\"Business Wire\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Business Wire\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"5 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/38-879-billion-heart-failure-devices-markets-global-forecast-to-2029-researchandmarkets-com\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/38-879-billion-heart-failure-devices-markets-global-forecast-to-2029-researchandmarkets-com\\\/\"},\"author\":{\"name\":\"Business Wire\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\"},\"headline\":\"$38.879 Billion Heart Failure Devices Markets &#8211; Global Forecast to 2029 &#8211; ResearchAndMarkets.com\",\"datePublished\":\"2023-04-20T17:03:12+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/38-879-billion-heart-failure-devices-markets-global-forecast-to-2029-researchandmarkets-com\\\/\"},\"wordCount\":1041,\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/38-879-billion-heart-failure-devices-markets-global-forecast-to-2029-researchandmarkets-com\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20230420005806\\\/en\\\/1770062\\\/21\\\/logo.jpg\",\"articleSection\":[\"Industry\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/38-879-billion-heart-failure-devices-markets-global-forecast-to-2029-researchandmarkets-com\\\/\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/38-879-billion-heart-failure-devices-markets-global-forecast-to-2029-researchandmarkets-com\\\/\",\"name\":\"$38.879 Billion Heart Failure Devices Markets - Global Forecast to 2029 - ResearchAndMarkets.com - Pharma Trend\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/38-879-billion-heart-failure-devices-markets-global-forecast-to-2029-researchandmarkets-com\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/38-879-billion-heart-failure-devices-markets-global-forecast-to-2029-researchandmarkets-com\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20230420005806\\\/en\\\/1770062\\\/21\\\/logo.jpg\",\"datePublished\":\"2023-04-20T17:03:12+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/38-879-billion-heart-failure-devices-markets-global-forecast-to-2029-researchandmarkets-com\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/pharma-trend.com\\\/en\\\/38-879-billion-heart-failure-devices-markets-global-forecast-to-2029-researchandmarkets-com\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/38-879-billion-heart-failure-devices-markets-global-forecast-to-2029-researchandmarkets-com\\\/#primaryimage\",\"url\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20230420005806\\\/en\\\/1770062\\\/21\\\/logo.jpg\",\"contentUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20230420005806\\\/en\\\/1770062\\\/21\\\/logo.jpg\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/38-879-billion-heart-failure-devices-markets-global-forecast-to-2029-researchandmarkets-com\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Startseite\",\"item\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"$38.879 Billion Heart Failure Devices Markets &#8211; Global Forecast to 2029 &#8211; ResearchAndMarkets.com\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"name\":\"Pharma Trend\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\",\"name\":\"Pharma Trend\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"\",\"contentUrl\":\"\",\"caption\":\"Pharma Trend\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\",\"name\":\"Business Wire\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"$38.879 Billion Heart Failure Devices Markets - Global Forecast to 2029 - ResearchAndMarkets.com - Pharma Trend","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/pharma-trend.com\/en\/38-879-billion-heart-failure-devices-markets-global-forecast-to-2029-researchandmarkets-com\/","og_locale":"en_US","og_type":"article","og_title":"$38.879 Billion Heart Failure Devices Markets - Global Forecast to 2029 - ResearchAndMarkets.com - Pharma Trend","og_description":"DUBLIN&#8211;(BUSINESS WIRE)&#8211;The &#8220;Heart Failure Devices Global Market &#8211; Forecast To 2029&#8221; report has been added to ResearchAndMarkets.com&#8217;s offering. The heart failure devices global market expected to grow at high single-digit CAGR from 2022 to 2029 to reach $38,879.9 million by 2029. Factors such as increasing incidence of heart failure diseases, technological advancement in heart failure ... [Read more...]","og_url":"https:\/\/pharma-trend.com\/en\/38-879-billion-heart-failure-devices-markets-global-forecast-to-2029-researchandmarkets-com\/","og_site_name":"Pharma Trend","article_published_time":"2023-04-20T17:03:12+00:00","og_image":[{"url":"https:\/\/mms.businesswire.com\/media\/20230420005806\/en\/1770062\/21\/logo.jpg","type":"","width":"","height":""}],"author":"Business Wire","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Business Wire","Est. reading time":"5 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/pharma-trend.com\/en\/38-879-billion-heart-failure-devices-markets-global-forecast-to-2029-researchandmarkets-com\/#article","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/38-879-billion-heart-failure-devices-markets-global-forecast-to-2029-researchandmarkets-com\/"},"author":{"name":"Business Wire","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24"},"headline":"$38.879 Billion Heart Failure Devices Markets &#8211; Global Forecast to 2029 &#8211; ResearchAndMarkets.com","datePublished":"2023-04-20T17:03:12+00:00","mainEntityOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/38-879-billion-heart-failure-devices-markets-global-forecast-to-2029-researchandmarkets-com\/"},"wordCount":1041,"publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/38-879-billion-heart-failure-devices-markets-global-forecast-to-2029-researchandmarkets-com\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20230420005806\/en\/1770062\/21\/logo.jpg","articleSection":["Industry"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/pharma-trend.com\/en\/38-879-billion-heart-failure-devices-markets-global-forecast-to-2029-researchandmarkets-com\/","url":"https:\/\/pharma-trend.com\/en\/38-879-billion-heart-failure-devices-markets-global-forecast-to-2029-researchandmarkets-com\/","name":"$38.879 Billion Heart Failure Devices Markets - Global Forecast to 2029 - ResearchAndMarkets.com - Pharma Trend","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/#website"},"primaryImageOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/38-879-billion-heart-failure-devices-markets-global-forecast-to-2029-researchandmarkets-com\/#primaryimage"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/38-879-billion-heart-failure-devices-markets-global-forecast-to-2029-researchandmarkets-com\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20230420005806\/en\/1770062\/21\/logo.jpg","datePublished":"2023-04-20T17:03:12+00:00","breadcrumb":{"@id":"https:\/\/pharma-trend.com\/en\/38-879-billion-heart-failure-devices-markets-global-forecast-to-2029-researchandmarkets-com\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/pharma-trend.com\/en\/38-879-billion-heart-failure-devices-markets-global-forecast-to-2029-researchandmarkets-com\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/38-879-billion-heart-failure-devices-markets-global-forecast-to-2029-researchandmarkets-com\/#primaryimage","url":"https:\/\/mms.businesswire.com\/media\/20230420005806\/en\/1770062\/21\/logo.jpg","contentUrl":"https:\/\/mms.businesswire.com\/media\/20230420005806\/en\/1770062\/21\/logo.jpg"},{"@type":"BreadcrumbList","@id":"https:\/\/pharma-trend.com\/en\/38-879-billion-heart-failure-devices-markets-global-forecast-to-2029-researchandmarkets-com\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Startseite","item":"https:\/\/pharma-trend.com\/en\/"},{"@type":"ListItem","position":2,"name":"$38.879 Billion Heart Failure Devices Markets &#8211; Global Forecast to 2029 &#8211; ResearchAndMarkets.com"}]},{"@type":"WebSite","@id":"https:\/\/pharma-trend.com\/en\/#website","url":"https:\/\/pharma-trend.com\/en\/","name":"Pharma Trend","description":"","publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/pharma-trend.com\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/pharma-trend.com\/en\/#organization","name":"Pharma Trend","url":"https:\/\/pharma-trend.com\/en\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/","url":"","contentUrl":"","caption":"Pharma Trend"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24","name":"Business Wire"}]}},"_links":{"self":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/56063","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/comments?post=56063"}],"version-history":[{"count":0,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/56063\/revisions"}],"wp:attachment":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/media?parent=56063"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/categories?post=56063"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/tags?post=56063"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}